Cargando…
Anti-Cytomegalovirus Therapy: Whether and When to Initiate, Those Are the Questions
Cytomegalovirus (CMV) reactivation in patients with autoimmune bullous disease (AIBD) or severe drug eruption treated with immunosuppressive therapy was traditionally thought to be merely an epiphenomenon of the underlying immunosuppression. However, a detailed review of the clinical course of these...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325238/ https://www.ncbi.nlm.nih.gov/pubmed/35890096 http://dx.doi.org/10.3390/ph15070797 |